Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by product type

1.4.2. Market size breakdown, by analyte type

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by Product Type (2017–2030)

7.2.1. Instrument-specific controls market revenue, by type (2017–2030)

7.3. Market Revenue, by Analyte Type (2017–2030)

7.4. Market Revenue, by Application (2017–2030)

7.5. Market Revenue, by End User (2017–2030)

7.6. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by Product Type (2017–2030)

8.2.1. Instrument-specific controls market revenue, by type (2017–2030)

8.3. Market Revenue, by Analyte Type (2017–2030)

8.4. Market Revenue, by Application (2017–2030)

8.5. Market Revenue, by End User (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by Product Type (2017–2030)

9.2.1. Instrument-specific controls market revenue, by type (2017–2030)

9.3. Market Revenue, by Analyte Type (2017–2030)

9.4. Market Revenue, by Application (2017–2030)

9.5. Market Revenue, by End User (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by Product Type (2017–2030)

10.2.1. Instrument-specific controls market revenue, by type (2017–2030)

10.3. Market Revenue, by Analyte Type (2017–2030)

10.4. Market Revenue, by Application (2017–2030)

10.5. Market Revenue, by End User (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by Product Type (2017–2030)

11.2.1. Instrument-specific controls market revenue, by type (2017–2030)

11.3. Market Revenue, by Analyte Type (2017–2030)

11.4. Market Revenue, by Application (2017–2030)

11.5. Market Revenue, by End User (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by Product Type (2017–2030)

12.2.1. Instrument-specific controls market revenue, by type (2017–2030)

12.3. Market Revenue, by Analyte Type (2017–2030)

12.4. Market Revenue, by Application (2017–2030)

12.5. Market Revenue, by End User (2017–2030)

12.6. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by Product Type (2017–2030)

13.2.1. Instrument-specific controls market revenue, by type (2017–2030)

13.3. Market Revenue, by Analyte Type (2017–2030)

13.4. Market Revenue, by Application (2017–2030)

13.5. Market Revenue, by End User (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by Product Type (2017–2030)

14.2.1. Instrument-specific controls market revenue, by type (2017–2030)

14.3. Market Revenue, by Analyte Type (2017–2030)

14.4. Market Revenue, by Application (2017–2030)

14.5. Market Revenue, by End User (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by Product Type (2017–2030)

15.2.1. Instrument-specific controls market revenue, by type (2017–2030)

15.3. Market Revenue, by Analyte Type (2017–2030)

15.4. Market Revenue, by Application (2017–2030)

15.5. Market Revenue, by End User (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by Product Type (2017–2030)

16.2.1. Instrument-specific controls market revenue, by type (2017–2030)

16.3. Market Revenue, by Analyte Type (2017–2030)

16.4. Market Revenue, by Application (2017–2030)

16.5. Market Revenue, by End User (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by Product Type (2017–2030)

17.2.1. Instrument-specific controls market revenue, by type (2017–2030)

17.3. Market Revenue, by Analyte Type (2017–2030)

17.4. Market Revenue, by Application (2017–2030)

17.5. Market Revenue, by End User (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by Product Type (2017–2030)

18.2.1. Instrument-specific controls market revenue, by type (2017–2030)

18.3. Market Revenue, by Analyte Type (2017–2030)

18.4. Market Revenue, by Application (2017–2030)

18.5. Market Revenue, by End User (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by Product Type (2017–2030)

19.2.1. Instrument-specific controls market revenue, by type (2017–2030)

19.3. Market Revenue, by Analyte Type (2017–2030)

19.4. Market Revenue, by Application (2017–2030)

19.5. Market Revenue, by End User (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by Product Type (2017–2030)

20.2.1. Instrument-specific controls market revenue, by type (2017–2030)

20.3. Market Revenue, by Analyte Type (2017–2030)

20.4. Market Revenue, by Application (2017–2030)

20.5. Market Revenue, by End User (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by Product Type (2017–2030)

21.2.1. Instrument-specific controls market revenue, by type (2017–2030)

21.3. Market Revenue, by Analyte Type (2017–2030)

21.4. Market Revenue, by Application (2017–2030)

21.5. Market Revenue, by End User (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by Product Type (2017–2030)

22.2.1. Instrument-specific controls market revenue, by type (2017–2030)

22.3. Market Revenue, by Analyte Type (2017–2030)

22.4. Market Revenue, by Application (2017–2030)

22.5. Market Revenue, by End User (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by Product Type (2017–2030)

23.2.1. Instrument-specific controls market revenue, by type (2017–2030)

23.3. Market Revenue, by Analyte Type (2017–2030)

23.4. Market Revenue, by Application (2017–2030)

23.5. Market Revenue, by End User (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by Product Type (2017–2030)

24.2.1. Instrument-specific controls market revenue, by type (2017–2030)

24.3. Market Revenue, by Analyte Type (2017–2030)

24.4. Market Revenue, by Application (2017–2030)

24.5. Market Revenue, by End User (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by Product Type (2017–2030)

25.2.1. Instrument-specific controls market revenue, by type (2017–2030)

25.3. Market Revenue, by Analyte Type (2017–2030)

25.4. Market Revenue, by Application (2017–2030)

25.5. Market Revenue, by End User (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by Product Type (2017–2030)

26.2.1. Instrument-specific controls market revenue, by type (2017–2030)

26.3. Market Revenue, by Analyte Type (2017–2030)

26.4. Market Revenue, by Application (2017–2030)

26.5. Market Revenue, by End User (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by Product Type (2017–2030)

27.2.1. Instrument-specific controls market revenue, by type (2017–2030)

27.3. Market Revenue, by Analyte Type (2017–2030)

27.4. Market Revenue, by Application (2017–2030)

27.5. Market Revenue, by End User (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by Product Type (2017–2030)

28.2.1. Instrument-specific controls market revenue, by type (2017–2030)

28.3. Market Revenue, by Analyte Type (2017–2030)

28.4. Market Revenue, by Application (2017–2030)

28.5. Market Revenue, by End User (2017–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by Product Type (2017–2030)

29.2.1. Instrument-specific controls market revenue, by type (2017–2030)

29.3. Market Revenue, by Analyte Type (2017–2030)

29.4. Market Revenue, by Application (2017–2030)

29.5. Market Revenue, by End User (2017–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. LGC Limited

31.1.1. Business overview

31.1.2. Product and service offerings

31.2. Thermo Fisher Scientific Inc.

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. Bio-Rad Laboratories Inc.

31.3.1. Business overview

31.3.2. Product and service offerings

31.3.3. Key financial summary

31.4. F. Hoffmann-La Roche Ltd.

31.4.1. Business overview

31.4.2. Product and service offerings

31.4.3. Key financial summary

31.5. ZeptoMetrix LLC

31.5.1. Business overview

31.5.2. Product and service offerings

31.6. Quidel Corporation

31.6.1. Business overview

31.6.2. Product and service offerings

31.6.3. Key financial summary

31.7. Maine Molecular Quality Controls Inc.

31.7.1. Business overview

31.7.2. Product and service offerings

31.8. Microbiologics Inc.

31.8.1. Business overview

31.8.2. Product and service offerings

31.9. Bio-Techne Corporation

31.9.1. Business overview

31.9.2. Product and service offerings

31.9.3. Key financial summary

31.10. Qnostics Ltd.

31.10.1. Business overview

31.10.2. Product and service offerings

31.11. Fortress Diagnostics

31.11.1. Business overview

31.11.2. Product and service offerings

31.12. LGC Clinical Diagnostics Inc.

31.12.1. Business overview

31.12.2. Product and service offerings

31.13. Microbix Biosystems Inc.

31.13.1. Business overview

31.13.2. Product and service offerings

31.13.3. Key financial summary

31.14. bioMérieux SA

31.14.1. Business overview

31.14.2. Product and service offerings

31.14.3. Key financial summary

31.15. Anchor Molecular

31.15.1. Business overview

31.15.2. Product and service offerings

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 15 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 16 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 17 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 18 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 19 MAJOR WORLDWIDE MARKETS FOR MOLECULAR QUALITY CONTROLS, $M

FIG 20 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 21 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 22 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 23 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 24 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 25 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 26 EUROPE MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 27 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 28 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 29 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 30 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 31 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 32 APAC MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 33 APAC MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 34 APAC MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 35 APAC MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 36 APAC MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 37 APAC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 38 LATAM MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 39 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 40 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 41 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 42 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 43 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 MEA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 45 MEA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 46 MEA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 47 MEA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 48 MEA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 49 MEA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 50 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 51 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 52 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 53 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 54 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 55 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 56 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 57 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 58 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 59 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 60 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 61 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 62 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 63 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 64 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 65 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 66 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 67 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 68 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 69 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 70 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 71 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 72 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 73 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 74 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 75 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 76 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 77 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 78 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 79 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 80 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 81 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 82 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 83 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 84 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 85 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 86 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 87 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 88 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 89 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 90 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 91 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 92 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 93 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 94 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 95 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 96 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 97 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 98 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 99 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 100 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 101 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 102 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 103 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 104 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 105 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 106 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 107 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 108 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 109 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 110 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 111 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 112 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 113 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 114 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 115 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 116 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 117 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 118 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 119 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 120 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 121 QUIDEL CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 122 BIO-TECHNE CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 123 MICROBIX BIOSYSTEMS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 124 BIOMÉRIEUX SA – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

※参考情報 分子品質管理（Molecular Quality Controls）は、分子レベルでの品質を確保するための手法やプロセスを指します。この品質管理は、特にバイオテクノロジー、製薬、臨床検査などの分野で重要な役割を果たしています。分子品質管理は、試薬や製品の分子構造、純度、活性、安定性などを評価し、適切な品質を維持するための手段として使用されます。 分子品質管理の種類には、主に以下のものがあります。最初に、分析的品質管理があります。これは、化学的・生物学的手法を用いて、製品の品質を評価するプロセスです。具体的には、クロマトグラフィーや質量分析、PCR（ポリメラーゼ連鎖反応）などの技術を使用して、目的の分子を精確に分析します。これにより、製品の特性や不純物の存在をチェックすることができます。 次に、プロセス品質管理があります。この管理手法は、製造プロセス全体における品質を担保するためのもので、製品の開発から製造、流通に至るまでの各段階で品質が保持されるように設計されています。プロセスの各ステップで検査やバリデーションを行うことで、全体の品質を向上させることが可能です。 さらに、システム品質管理も重要です。これは、品質管理の文化を組織全体に浸透させ、継続的に品質を改善するための枠組みを確立することを目指します。スタッフの教育やトレーニング、品質指標の設定、フィードバックのループなどが含まれます。これにより、品質管理が単なるチェックリストにとどまらない、自発的な改善活動が促進されます。 分子品質管理の用途は多岐にわたります。まず、医薬品の製造においては、製品が安全で有効であることを確認するために重要です。特にバイオ医薬品では、細胞株の特性や生成過程において品質管理が不可欠です。これにより、異常な反応や副作用の発生を防ぎます。 次に、診断技術での役割も無視できません。分子診断では、遺伝子やRNA、タンパク質の分析を通じて、病気の早期発見や適切な治療法の選択に寄与します。この関連性から、分子品質管理は診断精度の向上にもつながります。 さらに、食品産業でも分子品質管理が求められます。食品の安全性や品質を確保するために、成分分析や微生物検査が行われることで、消費者に安心を提供しています。ここでは、サンプルの取り扱いや保存条件にも注意を払い、確実な分析結果を得ることが求められます。 分子品質管理に関連する技術も多く存在します。まず、高度な分析技術として、次世代シーケンシング（NGS）やリアルタイムPCRが挙げられます。これらの技術により、高感度かつ高精度な分子分析が行われ、質の高いデータが得られます。 加えて、バイオインフォマティクスやデータ分析技術も重要です。大量の生物学的データを管理・解析することにより、分子の挙動を理解し、品質確保に向けた意思決定が可能になります。また、機械学習を活用した予測モデルの構築により、品質管理プロセスの効率化も進んでいます。 このように、分子品質管理は様々な側面から製品の品質を保証する重要な活動です。多様な手法と関連技術を組み合わせることで、企業や研究機関は、より高品質な製品を提供し、社会に貢献することが可能になります。これからも分子品質管理は進化し続け、多くの分野での発展が期待されます。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/